MedPath

Ribozyome

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

Phase 2
Completed
Conditions
Kidney Cancer
First Posted Date
2004-02-16
Last Posted Date
2013-03-26
Lead Sponsor
Ribozyome
Registration Number
NCT00021021
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma, Non-Hodgkin
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Ribozyome
Target Recruit Count
5
Registration Number
NCT00002221
Locations
🇺🇸

City of Hope Natl Med Ctr, Duarte, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.